Skip to content

The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial

The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03864276
Enrollment
120
Registered
2019-03-06
Start date
2019-02-17
Completion date
2020-12-31
Last updated
2021-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis(Who Will Undergo Planed Liver Transplantation)

Brief summary

Prolonged corrected QT interval (QTc) has been observed in about half of patients with liver cirrhosis. Marked prolongation of QTc (ie, 500 msec) has been considered to be a risk factor for fatal ventricular arrhythmia, such as torsade de pointes,7,8 which has been reported in liver transplantation (LT) surgery. In a previous study, prolonged QTc interval ( 500 msec) was frequently observed throughout the procedure of LT, even among patients with baseline QTc 440 msec. Therefore, it is important to optimize electrolyte balance and hemodynamic status to reduce greater risk of perioperative arrhythmias. The investigators hypothesized that the change of QTc interval might be differ according to method of general anesthesia (inhalation agent vs. intravenous agent).

Interventions

DRUGinhalation (desflurane) group

Anesthesia is induced and maintained with desflurane and sufentanil

DRUGtotal intravenous (propofol) anesthesia

Anesthesia is induced and maintained with propofol and sufentanil

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

patients will be randomly allocated to 2 groups using computer-generated randomization method. Care provider will not be blinded to the group allocation, because anesthesiologists should be aware of the method of anesthesia.

Intervention model description

Arm 1: inhalation anesthesia (desflurane) group Arm 2: total intravenous anesthesia (propofol) group

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with liver cirrhosis who will undergo planned liver transplantation

Exclusion criteria

* 1\. emergent liver transplantation * 2\. unstable angina * 3\. recent MI(Myocardial Infarction) * 4\. uncontrolled hypertension (diastolic BP \> 110mmHg) * 5\. implantable cardiac defibrillator * 6\. severe obesity (BMI\>30kg/m2) * 7\. allergy to propofol

Design outcomes

Primary

MeasureTime frameDescription
QTc interval3 minutes after liver reperfusionThe investigator will assess the QTc interval 3 minutes after the reperfusion during liver transplantation.

Secondary

MeasureTime frameDescription
QTc intervalat the end of the surgeryThe investigator will assess the QTc interval at the end of liver transplantation.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026